JFG
FOLD

Jefferies Financial Group’s Amicus Therapeutics FOLD Stock Holding History

Jefferies Financial Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-143,700
Closed -$2.04M – 1741
2023
Q4 		$2.04M Sell
143,700
-30,900
-18% -$351K 0.01% 704
2023
Q3 		$2.12M Buy
174,600
+108,900
+166% +$1.4M 0.02% 607
2023
Q2 		$825K Buy
+65,700
New +$780K 0.01% 997

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jefferies Financial Group's FOLD Position: Q1 2026 in Review

Jefferies Financial Group reduced its Amicus Therapeutics (FOLD) stake by 76% in Q1 2026, selling an estimated $1.79M and leaving 40,300 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Jefferies Financial Group first reported a position in FOLD in Q2 2023 and has held it in 8 quarters since. The position peaked at $2.36M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Jefferies Financial Group held 40,300 shares of Amicus Therapeutics worth $583K as of Q1 2026.
  • Jefferies Financial Group sold 125,185 Amicus Therapeutics shares in Q1 2026, an estimated $1.79M.
  • Amicus Therapeutics made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1143 holding.
  • Jefferies Financial Group first reported a position in Amicus Therapeutics in Q2 2023 and has held it in 8 quarters since.
  • Jefferies Financial Group's Amicus Therapeutics position peaked at $2.36M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.